Historical shareholding details of DFA US Targeted Value Portfolio holdings in Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B (LGND)

Monthly changes of DFA US Targeted Value Portfolio shareholding in Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Dfa Us Targeted Value Portfolio 128,883 0.67%
Jan 31, 2025 Dfa Us Targeted Value Portfolio 128,883 0.67%
Dec 31, 2024 Dfa Us Targeted Value Portfolio 128,679 0.68%
Nov 30, 2024 Dfa Us Targeted Value Portfolio 128,679 0.68%
Oct 31, 2024 Dfa Us Targeted Value Portfolio 128,679 0.68%
Sep 30, 2024 Dfa Us Targeted Value Portfolio 128,679 0.68%
Aug 31, 2024 Dfa Us Targeted Value Portfolio 128,292 0.70%
Jul 31, 2024 Dfa Us Targeted Value Portfolio 128,292 0.70%
Jun 30, 2024 Dfa Us Targeted Value Portfolio 128,292 0.70%
May 31, 2024 Dfa Us Targeted Value Portfolio 128,292 0.71%
Apr 30, 2024 Dfa Us Targeted Value Portfolio 87,127 0.49%
Mar 31, 2024 Dfa Us Targeted Value Portfolio 86,602 0.48%
Feb 29, 2024 Dfa Us Targeted Value Portfolio 86,602 0.48%
Jan 31, 2024 Dfa Us Targeted Value Portfolio 86,602 0.49%
Dec 31, 2023 Dfa Us Targeted Value Portfolio 86,602 0.50%
Oct 31, 2023 Dfa Us Targeted Value Portfolio 86,234 0.49%
Sep 30, 2023 Dfa Us Targeted Value Portfolio 74,912 0.43%
Jul 31, 2023 Dfa Us Targeted Value Portfolio 53,238 0.31%
Jun 30, 2023 Dfa Us Targeted Value Portfolio 44,537 0.26%
Apr 30, 2023 Dfa Us Targeted Value Portfolio 29,977 0.17%

View all ownership details of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B